By NewsDesk  @infectiousdiseasenews

UF medicinal chemists report promising results from a study focused on new ways to of treating several types of antibiotic-resistant bacteria, advances that may help in the battle against MRSA, tuberculosis and other infectious pathogens.

Methicillin-resistant Staphylococcus aureus (MRSA)

Lead investigator Robert Huigens, Ph.D., an associate professor of medicinal chemistry in the UF College of Pharmacy and a member of the UF Health Cancer Center, synthesized a new series of more than 20 different halogenated phenazine, or HP, small molecules with his team.

“HP small molecules could lead to critical advances in the treatment of significant infections, including wounds and chronic infections,” he said. The research was the focus of the cover story in the American Chemical Society’s Journal of Medicinal Chemistry.

Read more at UF Health